atorvastatin has been researched along with Hypothyroidism in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Kowalcze, K; Krysiak, R; Okopień, B | 1 |
Carvalho, D; Rodrigues, E; Saavedra, A | 1 |
Gilowski, W; Krysiak, R; Okopien, B | 1 |
Knopp, RH; Krieger, EV | 1 |
Cording, SA; Newnham, HH; Rando, LP | 1 |
5 other study(ies) available for atorvastatin and Hypothyroidism
Article | Year |
---|---|
Thyroid Antibody Titers and Hypothalamic-Pituitary-Thyroid Axis Activity in Levothyroxine-Treated Women With Autoimmune Subclinical Hypothyroidism Receiving Atorvastatin or Metformin.
Topics: Atorvastatin; C-Reactive Protein; Female; Hashimoto Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Inflammation; Insulin Resistance; Metformin; Thyroid Hormones; Thyrotropin; Thyroxine | 2022 |
[Dyslipidemia Secondary to Hypothyroidism and Cholestasis].
Topics: Atorvastatin; Autoimmune Diseases; Cholestasis; Diabetes Mellitus; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Liver Cirrhosis, Biliary; Middle Aged; Obesity; Thyroxine; Withholding Treatment | 2020 |
Different effects of atorvastatin on metabolic and cardiovascular risk factors in hypercholesterolemic women with normal thyroid function and subclinical hypothyroidism.
Topics: Adult; Atorvastatin; Cardiovascular Diseases; Comorbidity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypothyroidism; Middle Aged; Risk Factors; Treatment Outcome | 2015 |
Hypothyroidism misdiagnosed as statin intolerance.
Topics: Anticholesteremic Agents; Atorvastatin; Diagnostic Errors; Dyslipidemias; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Male; Middle Aged; Myositis; Pyrroles | 2009 |
Successful reintroduction of statin therapy after myositis: was there another cause?
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hypothyroidism; Male; Myositis; Pyrroles; Simvastatin | 2004 |